Skip to content
thestock.space

As of 6 Nov 2026, Fortis Malar Hospitals trades at 532.6× trailing earnings, above the industry P/E of 47.7×, and the shares are 36% below their 52-week high. It earns ROCE of 14% and ROE of 13%, though net profit is above operating profit, which points to a one-off gain. It is a small-cap company with a market cap of ₹80 Cr, ranked 30th of 40 Medical Care Facilities companies by market cap; the shares fell 36% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹41.93
Day high
₹42.90
Day low
₹41.60
Prev. close
₹41.63
Volume
20.6K

Health check

1 fair · 2 to check
  • ReturnsBehind

    −36.3% over a year, better than 0 of 7 peers.

  • Price tagDistorted

    A one-off gain inflates profit, so P/E isn’t comparable right now.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityAverage

    ROCE 13.8% vs peer median 11.9%.

  • Balance sheetn/a

    Balance sheet figures aren’t reported.

  • Red flags5 to check

    Quarterly profit down 96.3% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹80 Cr, #30 of 40 in its industry by size.

Defensive

Beta 0.29 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹0 Cr · profit ₹0 Cr
Market cap
₹80 Cr
Small cap
P/E
532.6
Industry 47.7
Price to book
2.33
Peers 8.06
Dividend yield
0.00%
ROE
12.8%
Peers 12.8%
ROCE
13.8%
Peers 11.9%
Debt to equity
n/a
Debt ₹0.00 Cr
EPS (TTM)
₹0.08
OPM (TTM)
−37333.3%
Net margin 434.6%
Sales growth
−95.6%
Latest quarter vs a year ago
Profit growth
−96.3%
Latest quarter vs a year ago
Price to sales
2535.20

Strengths and risks

Risks to check

  • Quarterly profit down 96.3% on a year ago.
  • Quarterly sales down 95.6% on a year ago.
  • Net profit is above operating profit, so a one-off gain is likely flattering earnings.
  • P/E of 532.6 against an industry P/E of 47.7.
  • 36% below its 52-week high.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Fortis Malar Hospitals

Fortis Malar Hospitals Limited provides health care services in India. It operates and manages Fortis Malar Hospital, a multi-specialty hospital in Chennai. The company was formerly known as Malar Hospital. Fortis Malar Hospitals Limited was incorporated in 1989 and is based in Mohali, India. Fortis Malar Hospitals Limited is a subsidiary of Fortis Hospitals Limited.

Headquarters
Mohali
Sector
Healthcare
ISIN
INE842B01015

Price range

52 weeks

₹39.00₹66.30

Today

₹41.60₹42.90
Avg volume (3M)
6.4K
1-year return
minus 36.3%
From 52-week high
minus 35.7%

Peers · Medical Care Facilities

Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
FORTISMLRFortis Malar Hospitals42.61plus 2.35%80532.62.3313.8%12.8%−37333.3%––0.00%minus 36.3%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
0–––0
−4.3–––0.3
4.3−0.3−0.3−0.5−0.3
20902.0%–––−37233.3%
00.50.50.70.5
4.30.10.20.10.2
3.1%90.2%91.9%142.1%24.3%
4.200−00.2
2.220.010.01-0.020.08

Profit & loss

Yearly, ₹ crore
ROE
12.8%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
85.858.9––
8159.9––
4.8−1−2.1−1.5
5.6%−1.8%––
6.672.76.3
6.14.30–
12.19.4––
−0.357.8−0–
−7500.64.7
−120.9%9.4%31.0%12.5%
−15.545.30.44.1
––minus 99.1%+955.5%
-8.2624.180.212.21

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
–18.818.818.818.8
–45.490.711.515.6
53.446.4–––
–27.46.46.63.3
–13811636.837.6
5747.2–––
0––––
0.50.5–––
–9.410832.134.3
–80.97.64.83.3
–13811636.837.6

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
5.6−7.31.50.6
0.5120−29.10.5
−12.7−10.9−79.7–
−6.5102−1071.1
−1.9−2.3––
3.7−9.61.50.6
––−79.7–

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you